Table 1

Study characteristics

YearAuthorCountryStudy typeProcedureCase numberIntended follow-up (months)Mean age (years)Male (%)Mean BMINutrition management12 months missing rate (%)
1992Avinoah EIsraelProspectiveNR2009636.129.0NRNR0
1998Brolin REUSAProspectiveNR34836Oral MVI12.6
2006Madan AKUSARetrospectiveLaparoscopy10012NR64.0
2009Toh SYAustraliaRetrospectiveLaparoscopy121124836.443.1Oral MVI, B12#52.1
2010Avgerinos DVUSARetrospectiveNR2062040.819.9Oral MVI0
2011von Drygalski AUSAProspectiveBoth1125484211.250.1Oral MVI67.0
2011Cable CTUSARetrospectiveBoth10093643.715.9Oral MVI28.6
2012Blume CABrazilRetrospectiveNR1703639.520.048.8NR0
2012Dallal RMUSARetrospectiveNR5901243.217.247.7Fe*0
2012Aarts EOThe NetherlandsProspectiveLaparoscopy3771243.427.146.8Oral MVI0
2013Moizé VSpainProspectiveLaparoscopy2946045.22347.4Oral MVI, B12#0
2014Gesquiere IBelgiumRetrospectiveLaparoscopy16460432541.8Fe*45.1
2014Obinwanne KMUSARetrospectiveLaparoscopy95912043.815.147.4Oral MVI, Fe*17.9
2014Salgado W JrBrazilRetrospectiveOpen1024841.914.849.7Oral MVI4.9
2014Ledoux SFranceProspectiveLaparoscopy1443642.99.748.2Oral MVI, B12*0
  • Fe*: Therapeutic iron supplementation; B12*: therapeutic intramuscular vitamin B12.

  • B12#: Augmented with intramuscular vitamin B12 prophylaxis.

  • BMI, body mass index; NR, not reported; Oral MVI, prophylactic oral tablet with multivitamin and mineral supplement.